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Ruptured inflammatory abdominal aortic aneurysm:
Insights in clinical management and outcome
Andrew L. Tambyraja, MRCSEd, John A. Murie, MD, FRCSG, and Roderick T. A. Chalmers, MD,
FRCSEd, Edinburgh, Scotland
Background: Ruptured inflammatory abdominal aortic aneurysm (AAA) is relatively rare, and little has been written on
the outcome of operative treatment.
Methods: Patients undergoing attempted repair of ruptured inflammatory AAA between 1995 and 2001 were included in
a retrospective case-cohort study. Demographic, clinical, and operative factors were analyzed, together with in-hospital
morbidity, in-hospital mortality, and duration of postoperative hospital stay.
Results: Of 297 patients who underwent attempted operative repair of ruptured AAA, 24 (8%) had an inflammatory
aneurysm. Twenty-two patients were men, and two were women; median age was 69 years (range, 51-85 years). Operative
findings revealed a contained hematoma in 16 patients (70%), free rupture in 3 patients (13%), aortocaval fistula in 4
patients (17%), and aortoenteric fistula in 1 patient (4%). Of 273 noninflammatory ruptured AAAs, only 2 AAA (1%) were
associated with primary aortic fistula. Ten patients (42%) with inflammatory AAA died in hospital, compared with 117
of 273 patients (43%) without inflammation. Median postoperative stay was 10 days (range, 0-35 days). Of the 14
patients with inflammatory lesions who survived, 11 had postoperative complications; 4 patients had acute renal failure,
three of whom required temporary renal replacement therapy.
Conclusions: Ruptured inflammatory AAA is associated with a higher incidence of aortic fistula than is ruptured
noninflammatory AAA. Repair of ruptured inflammatory AAA is not associated with increased operative mortality
compared with repair of ruptured noninflammatory AAA. (J Vasc Surg 2004;39:400-3.)
The concept of inflammatory abdominal aortic aneu-
rysm (AAA) was first described by Walker et al1 to encom-
pass the findings of a thick, white, shiny aneurysm wall and
dense fibrosis involving adjacent structures. Reported inci-
dence ranges between 3% and 10%, with a marked male
preponderance.2 Inflammatory AAA presents a surgical
challenge because of the difficulty in dissection and control
of the proximal and distal aorta.3 Nevertheless, open repair
of intact inflammatory AAA is associated with a similar
operative mortality and long-term survival as open repair of
noninflammatory AAA.4-6
Inflammatory AAA is at lower risk for rupture com-
pared with noninflammatory AAA. Thus it is not surprising
that individual surgeons gain little experience in manage-
ment of ruptured inflammatory lesions.2,7 We describe the
management, clinical outcome, and long-term survival in
patients admitted to a large vascular surgery unit with
ruptured inflammatory AAA.
METHODS
All patients admitted to the Edinburgh Vascular Surgi-
cal Service for repair of AAA over 7 years from January 1995
to December 2001 were identified from a prospective
database and included in a retrospective case-cohort study.
The database, together with hospital records, provided
demographic details and clinical and operative information
for all patients undergoing attempted repair of ruptured
AAA. Ruptured aneurysm was defined as presence of retro-
peritoneal or intraperitoneal blood in the absence of any
other identifiable cause for hematoma other than an aneu-
rysm or acute development of an aortic fistula.8 Inflamma-
tory AAA was diagnosed on the basis of operative appear-
ance. An inflammatory AAA was characterized by the
presence of a thickened aneurysm wall, perianeurysm fibro-
sis, and adhesions to adjacent structures.2 Histologic con-
firmation was not routinely obtained. In-hospital morbidity
and mortality, length of hospital stay, and postoperative
survival were assessed. Survival data were obtained from
hospital and general practice records.
Statistical analysis was performed with SPSS for Win-
dows release 11.0.0 (SPSS, Chicago, Ill). Differences be-
tween groups were determined with the 2 or Fisher exact
test for categoric variables and the Mann-Whitney U test
for nonparametric continuous variables; P  .05 was con-
sidered significant. Kaplan-Meier life tables were used to
calculate survival.
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RESULTS
Patients and demographic data. Five hundred pa-
tients underwent attempted repair of nonruptured AAA
over the 7-year study. Of these, 54 patients (11%; 43 men
and 11 women) had evidence of inflammatory aneurysm.
Another 297 patients underwent attempted repair of rup-
tured AAA during the study, of which 24 aneurysms (8%)
were found to be inflammatory.
Patients with ruptured inflammatory AAA included 22
men and 2 women, with median age 69 years (range, 51-85
years). In 3 patients AAA had been diagnosed before
presentation, and in 1 of these patients inflammatory
AAA was diagnosed before operation. Of these 3 patients
one had been considered unsuitable for elective open re-
pair, because of prohibitive ischemic heart disease; 1
male patient had a small aneurysm, with anteroposterior
diameter 42 mm on ultrasound scans; and 1 had been
deemed unsuitable for open repair, because of the in-
flammatory process during a previous laparotomy at
another unit.
Preoperative findings. Six of the 24 patients were
transferred from other hospitals, with a diagnosis of rup-
tured AAA. Presenting symptoms are described in Table I.
In 12 of the 24 patients systolic blood pressure was 90
mm Hg before operation. Preoperatively, 4 patients under-
went computed tomography and 3 underwent ultrasound
scanning. Computed tomography scans in 2 patients dem-
onstrated features consistent with inflammatory AAA. One
patient, with an aortocaval fistula, had established renal
failure before surgery. For the group as a whole, preopera-
tive mean serum creatinine concentration was 124 m/L
(range, 68-642 m/L).
Operative findings. At operation, 16 patients had
evidence of a contained retroperitoneal hematoma and 3
had free intraperitoneal blood. Another 4 patients had
evidence of aortocaval fistula, and one had a primary aor-
toduodenal fistula. Of the 273 patients who underwent
attempted repair of ruptured noninflammatory AAA over
the study period, only 2 patients had a primary aortic fistula,
both aortocaval (P  .0001). In the group with inflamma-
tory AAA, 20 patients had an infrarenal AAA, 2 of juxtare-
nal origin, and 2 had evidence of suprarenal extension. In
13 of the 24 patients the aneurysm extended to the iliac
artery. No aneurysm was mycotic, as confirmed with sub-
sequent routine microbiologic examination of mural
thrombus.
Operative management. Operative technique in all
operations was through a transperitoneal approach, with
minimal dissection of adherent structures from the aneu-
rysm. Two patients with suprarenal lesions and 1 patient
with an aortoduodenal fistula died intraoperatively, and no
prosthesis was inserted. Of the 21 remaining patients,
infrarenal aortic clamping was performed in 19 and in 2
patients a balloon occlusion catheter was required for prox-
imal control. Standard operative practice entailed avoid-
ance of supraceliac clamping whenever possible. Eleven
patients received a bifurcated graft, and 10 received a
straight graft. All aortocaval fistulas were closed off from
within the AAA sac with polypropylene sutures. In 7 pa-
tients careful dissection and mobilization of the left renal
vein was required, and in 1 of these patients the vein was
ligated. No patient underwent ureterolysis, and there were
no iatrogenic enteric injuries.
Postoperative outcome. In-hospital mortality in the
inflammatory AAA series was 10 of 24 patients (42%).
Seven deaths were intraoperative or within 24 hours of
surgery, and three deaths occurred later. Of 273 patients
admitted with ruptured noninflammatory AAA during the
study period, 117 patients (43%) died in hospital (P 
.910), 69 intraoperatively or within 24 hours of surgery (P
 .495).
Of the 14 surviving patients in the inflammatory AAA
group, 11 had one or more postoperative complications
(Table II). Three patients required further surgery, one to
treat postoperative bleeding, one for femoral embolec-
tomy, and one for repair of a perforated duodenal ulcer. Of
156 surviving patients in the noninflammatory AAA group,
125 developed one or more postoperative complications (P
 .889).
Four patients developed acute renal failure after repair
of ruptured inflammatory AAA, and in 3 of these temporary
renal replacement therapy was required. No patient re-
quired permanent renal support. Of 4 patients who under-
went repair of aortocaval fistulas, postoperative lower limb
deep vein thrombosis developed in 2 patients. None died.
Median postoperative hospital stay for survivors of rup-
tured inflammatory AAA was 12 days (range, 9-35 days),
compared with 13 days (range, 8-129 days) for survivors of
ruptured noninflammatory lesions (P  .422)
Table I. Presenting symptoms in 24 patients with
ruptured inflammatory abdominal aortic aneurysm
Symptom
No. of
patients
Abdominal/back pain 14
Collapse 8
Hematemesis 1
Hematuria/oliguria/renal failure 1
Table II. Postoperative morbidity after successful repair
of ruptured inflammatory abdominal aortic aneurysm in
14 patients
Morbidity
No. of
patients
Renal failure 4
Left ventricular failure 3
Deep vein thrombosis 2
Myocardial Infarction 1
Perforated duodenal ulcer 1
Respiratory tract infection 1
Ileus 1
Limb ischemia 1
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Long-term survival. Median survival of the 14 pa-
tients discharged from the hospital was 42 months (range,
10-62 months; Fig). In 1 patient late renal failure devel-
oped, but this was not secondary to obstructive nephropa-
thy. No patient was discharged with steroid therapy, and
none have had postoperative graft complications.
DISCUSSION
To our knowledge, there are no other contemporary
series specifically describing management and outcome of
ruptured inflammatory AAA. The current retrospective
case-cohort study describes a single-center experience in
the management of such aneurysms.
It is recognized that the concept of inflammatory an-
eurysm does not entail a distinct clinicopathologic entity,
but one end of a spectrum of chronic inflammatory changes
seen in degenerative aneurysms.9 However, all patients in
the current series had the defining triad of thickened aneu-
rysm wall, extensive perianeurysm fibrosis, and dense adhe-
sions to adjacent organs, as described by Rasmussen and
Hallett.2
Risk for rupture of inflammatory AAA is generally
thought to be lower than that of noninflammatory AAA.2,7
Nevertheless, natural progression to enlargement and even-
tual rupture persists.1,2,7,9,10 Case-cohort studies have re-
ported the observed incidence of rupture to be between 3%
and 4% in inflammatory AAA, compared with 17% to 20%
in noninflammatory AAA, but these figures stem from
relatively small series.9,10 The present data show that the
relative proportions of inflammatory and noninflammatory
AAA that present with rupture do not exhibit such dispar-
ity; the true rate of rupture of inflammatory AAA may be
closer to that of noninflammatory lesions than previously
assumed.
Previous reports suggested that the combination of
lower rupture risk and higher perioperative mortality after
elective repair renders correct management of asymptom-
atic inflammatory AAA unclear.10 While it is impossible to
determine the true rate of incidence and rupture of inflam-
matory lesions without population-based screening and
prospective follow-up, the incidence of ruptured inflamma-
tory AAA in the current series does not support such a
conservative stance.
The incidence of obstructive uropathy in inflammatory
AAA is generally reported to be approximately 20%.4,9 It is
interesting that in the current series no patient had evidence
of significant renal failure that could be attributed to ob-
structive nephropathy. Nitecki et al,5 in a case-cohort study
of 29 intact inflammatory AAAs, reported no significant
differences in preoperative serum creatinine concentration
or incidence of chronic renal failure compared with patients
with noninflammatory AAA. However, patients with in-
flammatory aneurysms were at increased risk for postoper-
ative renal failure, and 11% required renal replacement
therapy. In the present series no patient had clinical evi-
dence of obstructive nephropathy; and only one had renal
failure, secondary to an aortocaval fistula. Despite this, 5 of
24 patients had postoperative renal failure and required
renal replacement therapy. However, it is recognized that
the etiology of postoperative nephropathy is quite different
after repair of ruptured AAAs compared with intact lesions.
Aortovenous fistula complicating rupture of an AAA
has an incidence of approximately 2% to 4%.11,12 Death
after operative repair of spontaneous aortocaval fistula has
been reported at 21% to 55%.13 From the present data, only
1% of noninflammatory AAAs were associated with aorto-
caval fistula, as opposed to 17% of inflammatory aneurysms.
Of interest, the only primary aortoenteric fistula in the
current series was in a patient with a ruptured inflammatory
AAA. Calligaro et al,11 in a review of aortovenous fistula
associated with ruptured AAA, cited four reports of aor-
tovenous fistula associated with inflammatory lesions, and
thought this reflected an increased predisposition for pos-
terior rather than anterior rupture, as a result of anterior
fibrosis and thickening. Together with recognition that
periaortic fibrosis causes adherence to posterior veins in
63% to 70% of inflammatory AAAs, an increased incidence
of aortovenous fistula is unsurprising.4
None of the 4 patients with aortocaval fistulas in the
present series died in hospital, although repair was associ-
ated with postoperative deep venous thrombosis in 2 pa-
tients, despite subcutaneous unfractionated heparin throm-
boprophylaxis. Postoperative deep venous thrombosis is a
noteworthy complication after repair of aortocaval fistula.
Measures to minimize risk may include therapeutic antico-
agulation postoperatively, followed by a period of oral
anticoagulation after discharge. It seems that heightened
Postoperative survival after successful repair of ruptured inflamma-
tory abdominal aortic aneurysm in 14 patients.
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awareness of the possibility of aortovenous fistula should
exist in management of ruptured inflammatory AAA. Sim-
ple closure of the fistula, together with insertion of an aortic
prosthesis, can be performed with acceptable morbidity and
mortality.
It is accepted that elective or urgent open repair of
intact inflammatory AAA can be performed with mortality
that approaches that of noninflammatory AAA repair.3,4,6
Outcome after repair of ruptured inflammatory lesions is
less well-recorded. Lindblad et al10 reported an operative
mortality rate or 75% in 4 patients with ruptured inflamma-
tory AAA, compared with 44% in 16 patients with ruptured
noninflammatory AAA, but it is impossible to derive a
meaningful conclusion from such a small series. The
present larger series exhibited a 42% operative in-hospital
mortality rate, similar to the operative in-hospital mortality
rate of 43% for ruptured noninflammatory AAA during the
study period.
Few analogous series describe the outcomes of endo-
vascular repair of inflammatory AAA. Hinchliffe et al,14 in a
series of 14 patients with intact inflammatory AAA, re-
ported a 14% mortality rate, although a potential role in
patients with previous failed open repair is proposed. Fur-
thermore, potential for endovascular stent grafting to exac-
erbate perianeurysm inflammatory fibrosis has been de-
scribed by Vallabhaneni et al.15 Although it is proposed
that endovascular techniques offer an alternative to open
repair of stable ruptured AAA, indications remain unclear in
both noninflammatory and inflammatory lesions.16
In conclusion, despite the operative challenge associ-
ated with repair of ruptured inflammatory lesions, the
inflammatory process itself has no appreciable immediate
effect in terms of outcome.
We thank Mr A. McL. Jenkins, Professor A. W. Brad-
bury, Mr J. Sathianathan, and Mr D. G. Kitts for allowing
us to report on their patients.
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